| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |